|
1
|
Pant S, Deshmukh A, Gurumurthy GS,
Pothineni NV, Watts TE, Romeo F and Mehta JL: Inflammation and
atherosclerosis- revisited. J Cardiovasc Pharmacol Ther.
19:170–178. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Weber C and Noels H: Atherosclerosis:
Current pathogenesis and therapeutic options. Nat Med.
17:1410–1422. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Eelen G, de Zeeuw P, Simons M and
Carmeliet P: Endothelial cell metabolism in normal and diseased
vasculature. Circ Res. 116:1231–1244. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rudijanto A: The role of vascular smooth
cells on the pathogenesis of atherosclerosis. Acta Med Indones.
39:86–93. 2007.PubMed/NCBI
|
|
5
|
Cersosimo E and DeFronzo RA: Insulin
resistance and endothelial dysfunction: The road map to
cardiovascular diseases. Diabetes Metab Res Rev. 22:423–436. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ebert MS and Sharp PA: Roles for microRNAs
in conferring robustness to biological processes. Cell.
149:515–524. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rogers K and Chen X: Biogenesis, turnover,
and mode of action of plant microRNAs. Plant Cell. 25:2383–2399.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hayes J, Peruzzi PP and Lawler S:
MicroRNAs in cancer: Biomarkers, functions and therapy. Trends Mol
Med. 20:460–469. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Qu Y and Zhang N: miR-365b-3p inhibits the
cell proliferation and migration of human coronary artery smooth
muscle cells by directly targeting ADAMTS1 in coronary
atherosclerosis. Exp Ther Med. 16:4239–4245. 2018.PubMed/NCBI
|
|
11
|
Wu CY, Zhou ZF, Wang B, Ke ZP, Ge ZC and
Zhang XJ: MicroRNA-328 ameliorates oxidized low-density
lipoprotein-induced endothelial cells injury through targeting
HMGB1 in atherosclerosis. J Cell Biochem. Oct 15–2018.(Epub ahead
of print).
|
|
12
|
de Ronde MWJ, Kok MGM, Moerland PD, Van
den Bossche J, Neele AE, Halliani A, van der Made I, de Winther
MPJ, Meijers JCM, Creemers EE and Pinto-Sietsma SJ: High miR-124-3p
expression identifies smoking individuals susceptible to
atherosclerosis. Atherosclerosis. 263:377–384. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen Z, Wang M, Huang K, He Q, Li H and
Chang G: MicroRNA-125b affects vascular smooth muscle cell function
by targeting serum response factor. Cell Physiol Biochem.
46:1566–1580. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
House R, Majumder M, Janakiraman H,
Ogretmen B, Kato M, Erkul E, Hill E, Atkinson C, Barth J, Day TA
and Palanisamy V: Smoking-induced control of miR-133a-3p alters the
expression of EGFR and HuR in HPV-infected oropharyngeal cancer.
PLoS One. 13:e02050772018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tang Y, Pan J, Huang S, Peng X, Zou X, Luo
Y, Ren D, Zhang X, Li R, He P and Wa Q: Downregulation of
miR-133a-3p promotes prostate cancer bone metastasis via activating
PI3K/AKT signaling. J Exp Clin Cancer Res. 37:1602018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang Y, Dun Y, Zhou S and Huang XH:
LncRNA HOXD-AS1 promotes epithelial ovarian cancer cells
proliferation and invasion by targeting miR-133a-3p and activating
Wnt/β-catenin signaling pathway. Biomed Pharmacother. 96:1216–1221.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gao L, Li SH, Tian YX, Zhu QQ, Chen G,
Pang YY and Hu XH: Role of downregulated miR-133a-3p expression in
bladder cancer: A bioinformatics study. Onco Targets Ther.
10:3667–3683. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Van den Steen PE, Dubois B, Nelissen I,
Rudd PM, Dwek RA and Opdenakker G: Biochemistry and molecular
biology of gelatinase B or matrix metalloproteinase-9(MMP-9). Crit
Rev Biochem Mol Biol. 37:375–536. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hobeika MJ, Thompson RW, Muhs BE, Brooks
PC and Gagne PJ: Matrix metalloproteinases in peripheral vascular
disease. J Vasc Surg. 45:849–857. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shin SS, Ko MC, Noh DH, Hwang B, Park Y,
Park SL, Kim WJ and Moon S: Morin inhibits PDGF-induced
proliferation, migration, and invasion of vascular smooth muscle
cells via modulating p27KIP1, AKT, and MMP-9 activities. Gen
Physiol Biophys. 37:633–645. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lu Y, Thavarajah T, Gu W, Cai J and Xu Q:
Impact of miRNA in Atherosclerosis. Arterioscler Thromb Vasc Biol.
38:e159–e170. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Feinberg MW and Moore KJ: MicroRNA
regulation of atherosclerosis. Circ Res. 118:703–720. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sun QR, Zhang X and Fang K: Phenotype of
vascular smooth muscle cells (VSMCs) is regulated by miR-29b by
targeting sirtuin 1. Med Sci Monit. 24:6599–6607. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li K, Pan J, Wang J, Liu F and Wang L:
miR-665 regulates VSMCs proliferation via targeting FGF9 and MEF2D
and modulating activities of Wnt/β-catenin signaling. Am J Transl
Res. 9:4402–4414. 2017.PubMed/NCBI
|
|
26
|
Szmitko PE, Wang CH, Weisel RD, Jeffries
GA, Anderson TJ and Verma S: Biomarkers of vascular disease linking
inflammation to endothelial activation: Part II. Circulation.
108:2041–2048. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Florence JM, Krupa A, Booshehri LM, Allen
TC and Kurdowska AK: Metalloproteinase-9 contributes to endothelial
dysfunction in atherosclerosis via protease activated receptor-1.
PLoS One. 12:e01714272017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Newby AC: Metalloproteinase expression in
monocytes and macrophages and its relationship to atherosclerotic
plaque instability. Arterioscler Thromb Vasc Biol. 28:2108–2114.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bendeck MP, Conte M, Zhang M, Nili N,
Strauss BH and Farwell SM: Doxycycline modulates smooth muscle cell
growth, migration, and matrix remodeling after arterial injury. Am
J Pathol. 160:1089–1095. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kunz J: Matrix metalloproteinases and
atherogenesis in dependence of age. Gerontology. 53:63–73. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Newby AC: Dual role of matrix
metalloproteinases (matrixins) in intimal thickening and
atherosclerotic plaque rupture. Physiol Rev. 85:1–31. 2005.
View Article : Google Scholar : PubMed/NCBI
|
